Cargando…
MicroRNA as a Potential Therapeutic Molecule in Cancer
Small noncoding RNAs, as post-translational regulators of many target genes, are not only markers of neoplastic disease initiation and progression, but also markers of response to anticancer therapy. Hundreds of miRNAs have been identified as biomarkers of drug resistance, and many have demonstrated...
Autores principales: | Szczepanek, Joanna, Skorupa, Monika, Tretyn, Andrzej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947269/ https://www.ncbi.nlm.nih.gov/pubmed/35326459 http://dx.doi.org/10.3390/cells11061008 |
Ejemplares similares
-
Harnessing Epigenetics for Breast Cancer Therapy: The Role of DNA Methylation, Histone Modifications, and MicroRNA
por: Szczepanek, Joanna, et al.
Publicado: (2023) -
MicroRNA-Mediated Regulation of Histone-Modifying Enzymes in Cancer: Mechanisms and Therapeutic Implications
por: Szczepanek, Joanna, et al.
Publicado: (2023) -
Characteristic of the Ascorbate Oxidase Gene Family in Beta vulgaris and Analysis of the Role of AAO in Response to Salinity and Drought in Beet
por: Skorupa, Monika, et al.
Publicado: (2022) -
Salt stress and salt shock differently affect DNA methylation in salt-responsive genes in sugar beet and its wild, halophytic ancestor
por: Skorupa, Monika, et al.
Publicado: (2021) -
Differences in the Concentration of Anti-SARS-CoV-2 IgG Antibodies Post-COVID-19 Recovery or Post-Vaccination
por: Tretyn, Andrzej, et al.
Publicado: (2021)